Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The company’s shares closed yesterday at $177.60.

Below, we take a look at Masimo (MASI), a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the ...

Masimo, the patient monitoring company known for its pulse oximetry devices, said Tuesday it has hired Katie Szyman as its next CEO. Szyman is worldwide president of advanced patient monitoring at ...

In examining recent analyst actions, we gain insights into how financial experts perceive Masimo. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings ...

Masimo MASI-0.85%decrease; red down pointing triangle appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of ...

Masimo, the patient monitoring company known for its pulse oximetry devices, said Tuesday it has hired Katie Szyman as its next CEO. Szyman is worldwide president of advanced patient monitoring at BD ...

Interim CEO Michelle Brennan, who took over after CEO Joe Kiani resigned, will become the chair of Masimo’s board. A weekly newsletter by David Pierce designed to tell you everything you need to ...

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...